Figure 4

Kaplan–Meier estimates of patients with CD4+CD56+ hematodermic neoplasm. Overall survival and disease-free survival of patients with BDCA-2 positive (dotted lines) and negative (straight lines) tumors as detected immunohistochemically are displayed.